Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement
- Disease/Condition
- Contraception
- Drug/Device/Intervention
- Lidocaine topical
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- Uniformed Services University of the Health Sciences
- Location
- Bethesda, United States of America
- Phase
- Phase 4
- Start date
- Jun 01, 2023
- End date
- Jan 01, 2024
- Enrollment
- 120 participants
Procedure time,Patient-reported pain level
The goal of this clinical trial is to perform a pilot study looking at the benefit of topical
 anesthetic application to the cervix by tampon prior to intra-uterine device insertion. The
 main question it aims to answer are:
 
 - Does patient tampon-applied local anesthetic prior to insertion of an intrauterine
 device (IUD) reduce procedural duration?
 
 - Does patient tampon-applied local anesthetic prior to insertion of an intrauterine
 device (IUD) reduce pain and improve patient perceptions of the procedure? Participants
 will place a tampon after dipping the tampon into the study-supplied medication (aqueous
 lidocaine or saline). Researchers will compare treatment and control groups to see if
 there is any difference in procedure time, difficulty or patient perceptions.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05890495
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05890495 through Pure Global AI's free database. This Phase 4 trial is sponsored by Uniformed Services University of the Health Sciences and is currently Not yet recruiting. The study focuses on Contraception. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.